[CANONE] YoY Annualized Quarter Result on 31-Dec-2020 [#4]

Stock
[CANONE] CAN-ONE BHD
Announcement Date
25-Feb-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
QoQ- 30.45%
YoY- -89.36%
Quarter Report
Latest QR
Upcoming QR
CANONE's Result
CANONE's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 3,053,791 3,167,924 2,692,713 2,530,126 2,284,180 1,227,219 1,136,336 17.90%
PBT 50,285 128,174 -67,247 12,000 897,365 65,210 82,427 -7.90%
Tax -21,662 -40,393 -39,100 68,917 44,829 -18,634 -18,852 2.34%
NP 28,623 87,781 -106,347 80,917 942,194 46,576 63,575 -12.44%
-
NP to SH 33,396 91,886 -51,493 76,418 717,974 46,576 63,575 -10.16%
-
Tax Rate 43.08% 31.51% - -574.31% -5.00% 28.58% 22.87% -
Total Cost 3,025,168 3,080,143 2,799,060 2,449,209 1,341,986 1,180,643 1,072,761 18.85%
-
Net Worth 1,851,490 1,825,857 1,734,372 1,780,489 1,733,027 830,773 793,246 15.16%
Dividend
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Div 7,686 7,686 7,686 7,686 11,529 7,686 7,686 0.00%
Div Payout % 23.02% 8.36% 0.00% 10.06% 1.61% 16.50% 12.09% -
Equity
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Net Worth 1,851,490 1,825,857 1,734,372 1,780,489 1,733,027 830,773 793,246 15.16%
NOSH 192,153 192,153 192,153 192,153 192,153 192,153 192,153 0.00%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 0.94% 2.77% -3.95% 3.20% 41.25% 3.80% 5.59% -
ROE 1.80% 5.03% -2.97% 4.29% 41.43% 5.61% 8.01% -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 1,589.25 1,648.65 1,401.34 1,316.72 1,188.73 638.67 591.37 17.90%
EPS 17.38 47.82 -26.80 39.77 373.65 24.24 33.09 -10.17%
DPS 4.00 4.00 4.00 4.00 6.00 4.00 4.00 0.00%
NAPS 9.6355 9.5021 9.026 9.266 9.019 4.3235 4.1282 15.16%
Adjusted Per Share Value based on latest NOSH - 192,153
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 1,589.25 1,648.65 1,401.34 1,316.72 1,188.73 638.67 591.37 17.90%
EPS 17.38 47.82 -26.80 39.77 373.65 24.24 33.09 -10.17%
DPS 4.00 4.00 4.00 4.00 6.00 4.00 4.00 0.00%
NAPS 9.6355 9.5021 9.026 9.266 9.019 4.3235 4.1282 15.16%
Price Multiplier on Financial Quarter End Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 -
Price 2.43 3.37 3.69 2.79 2.87 1.98 2.89 -
P/RPS 0.15 0.20 0.26 0.21 0.24 0.31 0.49 -17.89%
P/EPS 13.98 7.05 -13.77 7.02 0.77 8.17 8.73 8.15%
EY 7.15 14.19 -7.26 14.25 130.19 12.24 11.45 -7.54%
DY 1.65 1.19 1.08 1.43 2.09 2.02 1.38 3.02%
P/NAPS 0.25 0.35 0.41 0.30 0.32 0.46 0.70 -15.76%
Price Multiplier on Announcement Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 22/02/24 23/02/23 24/02/22 25/02/21 28/02/20 28/02/19 28/02/18 -
Price 2.45 3.10 3.29 2.87 2.97 2.69 2.85 -
P/RPS 0.15 0.19 0.23 0.22 0.25 0.42 0.48 -17.61%
P/EPS 14.10 6.48 -12.28 7.22 0.79 11.10 8.61 8.56%
EY 7.09 15.43 -8.15 13.86 125.81 9.01 11.61 -7.88%
DY 1.63 1.29 1.22 1.39 2.02 1.49 1.40 2.56%
P/NAPS 0.25 0.33 0.36 0.31 0.33 0.62 0.69 -15.55%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment